← Back
$ANTX All transactions

AN2 Therapeutics, Inc.

▼ SELL

$ Value

$18K

Shares

17,923

Price

$1

Filed

Jan 7

Insider

Name

Eizen Joshua M

Title

See Remarks

CIK

0001949621

Roles

Officer

Transaction Details

Transaction Date

2026-01-05

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

159,430

Footnotes

Represents shares sold pursuant to the terms of the grant to satisfy tax withholding obligations arising from the vesting of Restricted Stock Units ("RSUs") on January 1, 2026. | This transaction was executed in multiple trades at prices ranging from $1.001 to $1.003 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | Includes (a) 30,000 RSUs which vest as follows: 1/4th of the RSUs vest annually over four years from January 1, 2024, (b) 60,000 RSUs which vest as follows: 25% of the RSUs vest on January 1, 2025, 50% of the RSUs vest on January 1, 2026, and 25% of the RSUs vest on July 1, 2026, (c) 31,500 RSUs which vest as follows: 1/4th of the RSUs vest annually over four years from November 4, 2024, and (d) 58,500 RSUs which vest as follows: 1/4th of the RSUs vest annually over four years from January 1, 2025, in each case subject to the Reporting Person's continuous service as of such date.

Filing Info

Accession No.

0001193125-26-006763

Form Type

4

Issuer CIK

0001880438

Eizen Joshua M's History

Date Ticker Type Value
2026-03-19 ANTX A
2026-03-19 ANTX D
2026-03-19 ANTX A
2026-03-19 ANTX D
2026-02-20 ANTX A $0
2026-02-20 ANTX A $0
2026-01-06 ANTX $7K
2026-01-05 ANTX $18K
2025-11-04 ANTX $3K

Other Insiders at ANTX (90d)

Insider Bought Sold Last
Zakrzewski Joseph S 2026-03-19
Spigelman Melvin K 2026-03-19
Wong Stephanie 2026-03-19
Chanda Sanjay
Chief Development Officer
2026-03-19
FitzPatrick Margaret M 2026-03-19
Easom Eric
Chief Executive Officer
2026-03-19
Day Lucy
Chief Financial Officer
2026-03-19
Aziz Kabeer 2026-04-10
Readnour Robin Shane 2026-03-19
Martin Patricia A. 2026-04-10
Marks Gilbert Lynn 2026-04-10
Eizen Joshua M
See Remarks
2026-03-19
Williams Sarah Joanne
Principal Accounting Officer
$347 2026-03-03